Nuformix Plc

As of March 31, 2026, Nuformix Plc carries a market capitalization of 439.74M, placing it among publicly traded companies globally. Its enterprise value stands at 346.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Nuformix Plc's next confirmed earnings release is scheduled for December 2, 2026.

As of March 31, 2026, Nuformix Plc has 2.61B shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Nuformix Plc maintains a current ratio of 4.32, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Nuformix Plc's stock has declined approximately 66.61% over the past 52 weeks. The 50-day moving average sits at 0.14, while the 200-day moving average is 0.18.

These figures are as of March 31, 2026. Total book value stands at 163.64M, with working capital of 75.37M providing operational flexibility.

Nuformix Plc's most recent stock split took place on October 28, 2025 with a 109:111 split ratio.